bullish
Olympus (7733 JP) Q4FY22: Net Profit More Than Doubled; Record High Profit Projection for FY23
339 Views13 May 2022 00:54
SUMMARY
- Olympus Corp (7733 JP) reported strong double-digit revenue growth in Q4 on continued medical business recovery. Net profit has more than doubled and 40% ahead of consensus.
- The company has achieved growth to above pre-pandemic level in FY22 and CAGR of >7% over last two years. Operating margin improved significantly to 19.3%.
- Olympus is on track to achieve more than 20% operating margin in FY23. Management projected a record high net profit of ¥154 billion for FY23.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Olympus Corp (7733 JP): FY23 Result Missed Expectation; Initiated Muted FY24 Forecast21 May 2023
- Olympus Placement - Had Been Doing Well, till Recently15 Nov 2022
- Olympus Corp (7733 JP): Started FY23 on a Strong Note Thanks to Favorable Foreign Exchange Rate16 Aug 2022
- Olympus (7733 JP): Medical Business Is on a Strong Foothold; Buy at Current Level26 Oct 2021
- Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?25 Jun 2018
x